ReP USP - Resultado da busca

Artigo de periodico
Intravenous NPA for the treatment of infarcting myocardium early (2000)
Marin-Neto, José Antônio
Fonte: European Heart Journal. Unidade: FMRP
Assunto: CARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARIN-NETO, José Antônio. Intravenous NPA for the treatment of infarcting myocardium early. European Heart Journal, v. 21, p. 2005-2013, 2000Tradução . . Acesso em: 06 nov. 2024.
APA
Marin-Neto, J. A. (2000). Intravenous NPA for the treatment of infarcting myocardium early. European Heart Journal, 21, 2005-2013.
NLM
Marin-Neto JA. Intravenous NPA for the treatment of infarcting myocardium early. European Heart Journal. 2000 ; 21 2005-2013.[citado 2024 nov. 06 ]
Vancouver
Marin-Neto JA. Intravenous NPA for the treatment of infarcting myocardium early. European Heart Journal. 2000 ; 21 2005-2013.[citado 2024 nov. 06 ]
Artigo de periodico
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease (2000)
Marin-Neto, José Antônio (colab)
Fonte: European Heart Journal. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES (EPIDEMIOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, v. 21, p. 2033-2041, 2000Tradução . . Acesso em: 06 nov. 2024.
APA
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. (2000). The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal, 21, 2033-2041.
NLM
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 nov. 06 ]
Vancouver
The clopidogrel in unstable angina to prevent recurrent events (CURE) trial programme: Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. European Heart Journal. 2000 ; 21 2033-2041.[citado 2024 nov. 06 ]
Trabalho de evento-resumo periodico
LDL receptor mRNA expression in mononuclear leukocytes from patients with severe hypercholesterolemia treated with HMG-CoA reductase inhibitor Atorvastatin (2000)
Salazar, Luís Antônio; Hirata, Mario Hiroyuki ; Forti, Neusa Assumpta; Diament, Jayme; Giannini, Sérgio Diogo; Hirata, Rosario Dominguez Crespo
Fonte: European Heart Journal. Nome do evento: Congress of the European Society of Cardiology. Unidades: FCF, FM
Assuntos: TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO, CARDIOLOGIA, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALAZAR, Luís Antônio et al. LDL receptor mRNA expression in mononuclear leukocytes from patients with severe hypercholesterolemia treated with HMG-CoA reductase inhibitor Atorvastatin. European Heart Journal. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2000
APA
Salazar, L. A., Hirata, M. H., Forti, N. A., Diament, J., Giannini, S. D., & Hirata, R. D. C. (2000). LDL receptor mRNA expression in mononuclear leukocytes from patients with severe hypercholesterolemia treated with HMG-CoA reductase inhibitor Atorvastatin. European Heart Journal. London: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Salazar LA, Hirata MH, Forti NA, Diament J, Giannini SD, Hirata RDC. LDL receptor mRNA expression in mononuclear leukocytes from patients with severe hypercholesterolemia treated with HMG-CoA reductase inhibitor Atorvastatin. European Heart Journal. 2000 ; 21 154.[citado 2024 nov. 06 ]
Vancouver
Salazar LA, Hirata MH, Forti NA, Diament J, Giannini SD, Hirata RDC. LDL receptor mRNA expression in mononuclear leukocytes from patients with severe hypercholesterolemia treated with HMG-CoA reductase inhibitor Atorvastatin. European Heart Journal. 2000 ; 21 154.[citado 2024 nov. 06 ]

Unidades USP

ReP

Filtros

Autores

Indexado em